Prevalence of Functional Bowel Disorders in Tehran Province: A Population-Based Study
DOI:
https://doi.org/10.22100/jkh.v6i3.105Keywords:
Functional bowel disorders, Irritable bowel disorder, Bloating, Constipation, Diarrhea, Rome III.Abstract
Introduction: The estimated prevalence of functional bowel disorders and its subtypes varies enormously depending on the diagnostic criteria employed. This study aimed at estimating the prevalence and risk factors of functional bowel disorders in an Iranian community.
Methods: This study was a cross-sectional household survey conducted from May 2006 to December 2007 in Tehran province, including 18,180 participants who were randomly selected and interviewed face-to-face using a validated questionnaire based on Rome III.
Results: In general, 1.1% of the participants met the Rome III criteria for Irritable bowel syndrome (IBS), 1.5% for functional bloating (FB), 2.4% for functional constipation (FC),5.5% for unspecified functional bowel disorder (U-FBD), 0.4% for functional diarrhea (FD) and 10.9% of the participants had at least one type of Functional bowel disorders (FBD). Interestingly, among participants with Functional Dyspepsia, Diarrhea, Bloating, Constipation and Abdominal pain; 83.8%, 78.6%, 77.2%, 74.55%, 72.9% respectively had FBD.
Conclusion: This study revealed low rate of Functional Bowel Disorders among urban population of Tehran province. The Rome III criteria itself, and the problems with interpretation of the data collection tool might have taken part in underestimating the prevalence of FBD. In addition the reliability of recall over 6 months in ROME III is questionable for our population.
References
Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology 2006;130(5):1377-90.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional Bowel Disorders. Gastroenterology 2006;130(5):1480-91.
Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional Gastrointestinal Disorders in Canada: First Population-Based Survey Using Rome II Criteria with Suggestions for Improving the Questionnaire. Dig Dis Sci 2002;47(1):225-35.
Sperber AD, Shvartzman P, Friger M, Fich A. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 2005;17(2):207-11.
Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran. Int J Colorectal Dis 2006;21(8):814-25.
Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004;20:31-9.
Delvaux M. Functional bowel disorders and irritable bowel syndrome in Europe. Aliment Pharmacol Ther 2003;18:75-9.
Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005;21(6):663-76.
Chang FY, Lu CL. Irritable bowel syndrome in the 21st century: Perspectives from Asia or South-east Asia. J Gastroenterol Hepatol 2007;22(1):4-12.
Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol 2003;22(6):215-6.
Ghannadi K, Emami R, Bashashati M, Tarrahi MJ, Attarian S. Irritable bowel syndrome: an epidemiological study from the west of Iran. Indian J Gastroenterol 2005;24(5):225-6.
Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7(5):427-33.
Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17(5):643-50.
Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21(11):1365-75.
Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical students. J Gastroenterol Hepatol 2003;18(12):1412-6.
Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004;19(11):1217-24.
Sperber AD, Friger M, Shvartzman P, Abu-Rabia M, Abu-Rabia R, Abu-Rashid M et al. Rates of functional bowel disorders among Israeli Bedouins in rural areas compared with those who moved to permanent towns. Clin Gastroenterol Hepatol 2005;3(4):342-8.
Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101(4):927-34.
Everhart JE, Go VL, Johannes RS, Fitzsimmons SC, Roth HP, White LR. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989;34(8):1153-62.
Zarghi A, Pourhoseingholi MA, Habibi M, Nejad MR, Ramezankhani A, Zali MR. Prevalence of gastrointestinal symptoms in the population of Tehran, Iran. Trop Med Int Health 2007; 12(supplement):181-182.[Persian].
Zarghi A, Pourhoseingholi MA, Habibi M, Haghdost AA,, Solhpour A, Moazezi M, et al. Prevalence of gastrointestinal symptoms and the influence of demographic factors. Am J Gastroenterol 2007;102(supplement):441-441.[Persian].
Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Habibi M, Ghafarnejad F, et al. Gastro-esophageal reflux symptoms and body
Barzkar M, Pourhoseingholi MA, Habibi M, Moghimi-Dehkordi B, Safaee A, Pourhoseingholi A, et al. Uninvestigated dyspepsia and its related factors in an Iranian community. Saudi Med J 2009;30(3):397-402.
Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, Moghimi-Dehkordi B, Safaee A, Mansoori BK, et al. Obesity and functional constipation; a community-based study in Iran. J Gastrointestin Liver Dis 2009;18(2):151-5.
Bommelaer G, Poynard T, Le Pen C, Gaudin AF, Maurel F, Priol G et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004;28(6-7):554-61.
Lau EM, Chan FK, Ziea ET, Chan CS, Wu JC, Sung JJ. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 2002;47(11):2621-4.
Celebi S, Acik Y, Deveci SE, Bahcecioglu IH, Ayar A, Demir A, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004;19(7):738-43.
Wei X, Chen M, Wang J. The epidemiology of irritable bowel syndrome and functional constipation of Guangzhou residents. Zhonghua Nei Ke Za Zhi 2001;40(8):517-20.
Karaman N, Türkay C, Yönem O. Irritable bowel syndrome prevalence in city center of Sivas. Turk J Gastroenterol 2003;14(2):128-31.
Si JM, Chen SJ, Sun LM. An epidemiological and quality of life study of irritable bowel syndrome in Zhejiang province. Zhonghua Nei Ke Za Zhi 2003;42(1):34-7.
Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001;96(11):3130-7.
Lu CL, Chen CY, Lang HC, Luo JC, Wang SS, Chang FY, et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment Pharmacol Ther 2003;18(11-12):1159-69.
Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004;99(5):924-31.
Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001;20(3):103-6.
Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998;93(10):1816-22.
mass index: no relation among the Iranian population. Indian J Gastroenterol 2008;27(4):153-5.
Hasler WL, Schoenfeld P. Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17(8):997-1005.
Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002;17(11):1180-6.
Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community; consulters and nonconsulters. Gastroenterology 1992;102(6):1962-7.
Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15(2):165-72.
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: A population-based study. Gastroenterology 1993;105(3):781-90.
Campbell AJ, Busby WJ, Horwath CC. Factors associated with constipation in a community based sample of people aged 70 years and over. J Epidemiol Community Health 1993;47(1):23-6.
Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health 1990;80(2):185-9.
Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: A population-based study. Gastroenterology 1992;102(3):895-901.
Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, et al. Constipation in an elderly community: A study of prevalence and potential risk factors. Am J Gastroenterol 1996;91(1):19-25.
Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology 1990;98(2):380-6.
Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000;45(6):1166-71.
Talley N, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42(5):690-5.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
